Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now

NCT02835599 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02835599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02835599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
November 1, 2016
Completion date
April 6, 2017
Enrollment
23 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer